CATX Perspective Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: CATX

Price (delayed)

$1.58

Market cap

$927.33M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.17

Enterprise value

$920.46M

Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium Blu brachytherapy seeds, which are expanding brachytherapy treatment options throughout the body.

Highlights
Perspective Therapeutics's gross profit has soared by 164% YoY and by 35% from the previous quarter
The debt has declined by 23% since the previous quarter
The revenue has surged by 127% year-on-year but it has dropped by 69% since the previous quarter
CATX's equity is up by 38% year-on-year but it is down by 24% since the previous quarter
Perspective Therapeutics's EPS has plunged by 143% YoY and by 70% from the previous quarter
The company's quick ratio has shrunk by 96% YoY and by 72% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.isoray.com
Peers: NVRO OFIX NURO

Key stats

What are the main financial stats of CATX
Market
Shares outstanding
586.92M
Market cap
$927.33M
Enterprise value
$920.46M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.9
Price to sales (P/S)
294.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
641.88
Earnings
Revenue
$1.43M
EBIT
-$49.08M
EBITDA
-$48.01M
Free cash flow
-$37.99M
Per share
EPS
-$0.17
Free cash flow per share
-$0.14
Book value per share
$0.27
Revenue per share
$0.01
TBVPS
$0.09
Balance sheet
Total assets
$97.89M
Total liabilities
$22.71M
Debt
$2.55M
Equity
$75.18M
Working capital
$1.17M
Liquidity
Debt to equity
0.03
Current ratio
1.07
Quick ratio
0.68
Net debt/EBITDA
0.14
Margins
EBITDA margin
-3,348.3%
Gross margin
100%
Net margin
-3,243.2%
Operating margin
-2,855%
Efficiency
Return on assets
-40.8%
Return on equity
-46.4%
Return on invested capital
-690%
Return on capital employed
-59.7%
Return on sales
-3,422.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CATX stock price

How has the Perspective Therapeutics stock price performed over time
Intraday
-1.25%
1 week
5.33%
1 month
27.42%
1 year
174.97%
YTD
293.03%
QTD
32.77%

Financial performance

How have Perspective Therapeutics's revenue and profit performed over time
Revenue
$1.43M
Gross profit
$1.43M
Operating income
-$40.94M
Net income
-$46.51M
Gross margin
100%
Net margin
-3,243.2%
Perspective Therapeutics's gross profit has soared by 164% YoY and by 35% from the previous quarter
The revenue has surged by 127% year-on-year but it has dropped by 69% since the previous quarter
The net income has plunged by 85% from the previous quarter
The operating income has contracted by 19% from the previous quarter

Growth

What is Perspective Therapeutics's growth rate over time

Valuation

What is Perspective Therapeutics stock price valuation
P/E
N/A
P/B
5.9
P/S
294.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
641.88
Perspective Therapeutics's EPS has plunged by 143% YoY and by 70% from the previous quarter
CATX's P/B is 119% above its 5-year quarterly average of 2.7
CATX's equity is up by 38% year-on-year but it is down by 24% since the previous quarter
The revenue has surged by 127% year-on-year but it has dropped by 69% since the previous quarter

Efficiency

How efficient is Perspective Therapeutics business performance
CATX's ROIC has shrunk by 196% QoQ
The ROE has plunged by 155% YoY and by 76% from the previous quarter
The ROA has plunged by 139% YoY and by 69% from the previous quarter

Dividends

What is CATX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CATX.

Financial health

How did Perspective Therapeutics financials performed over time
The company's quick ratio has shrunk by 96% YoY and by 72% QoQ
The current ratio has dropped by 94% year-on-year and by 60% since the previous quarter
The debt is 97% smaller than the equity
CATX's equity is up by 38% year-on-year but it is down by 24% since the previous quarter
The debt has declined by 23% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.